This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by ARONOFF, S. L. Articles by UNGER, R. H. Search for Related Content PubMed PubMed Citation Articles by ARONOFF, S. L. Articles by UNGER, R. H.

Immunoreactive Glucagon (IRG) Responses to Intravenous Glucose in Prediabetes and Diabetes Among Pima Indians and Normal Caucasians

Southwestern Field Studies Section, Epidemiology Phoenix, Arizona 85014 Field Studies Branch, National Institute of Arthritis, Metabolism Phoenix, Arizona 85014 Digestive Diseases, 1440 East Indian School Road, Phoenix Phoenix, Arizona 85014

Immunoreactive glucagon (IRG) response to a 3 min iv infusion of 25 g glucose was examined in 7 nondiabetic Caucasians, 8 nondiabetic, 8 prediabetic and 16 diabetic Pima Indians to define the normal IRG response and to determine if abnormalities of IRG suppression occur in diabetic and prediabetic Pima Indians. Fasting IRG levels were similar in the 3 nondiabetic groups. In response to the glucose infusion the maximum percentage fall in plasma IRG concentration was similar in the normal Caucasians (37±4%) and the normal (42±2%) and prediabetic Indians (43±3%). In the diabetic Indians the relative fall was less at all sampling times than among the prediabetic or normal Indians. No evidence of any differences in IRG suppression in prediabetic and normal Indians or normal Caucasians was found. Without detectable change in insulin levels during the first 10 min following the glucose infusion, IRG levels in the diabetics fell but to a lesser degree than that in the other groups.

Supported in part by National Institutes of Health contract NO1-AM-6-2219.

Received October 12, 1976.

This article has been cited by other articles:

				B. E. Dunning and J. E. Gerich The Role of {alpha}-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications Endocr. Rev., May 1, 2007; 28(3): 253 - 283. [Abstract] [Full Text] [PDF]

				R. Unger Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells Science, March 8, 1991; 251(4998): 1200 - 1205. [Abstract] [PDF]